Bellerophon Therapeutics Company Profile (NASDAQ:BLPH)

About Bellerophon Therapeutics

Bellerophon Therapeutics logoBellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Company is focused on the development of its nitric oxide therapy for patients with pulmonary hypertension (PH), using its delivery system, INOpulse, with pulmonary arterial hypertension (PAH) as the lead indication. Its INOpulse device has a mechanism that delivers brief, targeted pulses of nitric oxide timed to occur at the beginning of a breath for delivery to the alveoli of the lungs, which minimizes the amount of drug required for treatment. The Company's second program, BCM, is a medical device focused to prevent congestive heart failure following a ST Segment Elevation Myocardial Infarction (STEMI), which is a type of severe heart attack. The Company's BCM is in PRESERVATION I clinical trial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BLPH
  • CUSIP:
Key Metrics:
  • Previous Close: $1.43
  • 50 Day Moving Average: $1.53
  • 200 Day Moving Average: $1.85
  • 52-Week Range: $1.09 - $7.64
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.19
  • P/E Growth: 0.00
  • Market Cap: $21.75M
  • Outstanding Shares: 14,599,000
  • Beta: -2.54
Profitability:
  • Return on Equity: -119.05%
  • Return on Assets: -94.21%
Debt:
  • Current Ratio: 3.00%
  • Quick Ratio: 3.00%
Additional Links:
Companies Related to Bellerophon Therapeutics:

Analyst Ratings

Consensus Ratings for Bellerophon Therapeutics (NASDAQ:BLPH) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (615.88% upside)

Analysts' Ratings History for Bellerophon Therapeutics (NASDAQ:BLPH)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Cowen and CompanyReiterated RatingBuyView Rating Details
3/22/2016FBR & CoReiterated RatingOutperform$11.00View Rating Details
3/22/2016Leerink SwannLower Price TargetOutperform$11.00 -> $9.00View Rating Details
3/16/2015SunTrust Banks Inc.Initiated CoverageBuy$23.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Bellerophon Therapeutics (NASDAQ:BLPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/9/2016Q216($0.51)($0.39)ViewN/AView Earnings Details
5/10/2016Q116($0.65)($0.54)ViewN/AView Earnings Details
3/21/2016Q4($1.06)($0.82)ViewListenView Earnings Details
11/12/2015Q315($0.94)($0.86)ViewN/AView Earnings Details
4/1/2015($2.16)($1.62)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bellerophon Therapeutics (NASDAQ:BLPH)
Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.25 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.83)($0.42)($0.61)
Q2 20163($0.61)($0.46)($0.53)
Q3 20163($0.43)($0.35)($0.38)
Q4 20163($0.37)($0.30)($0.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bellerophon Therapeutics (NASDAQ:BLPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bellerophon Therapeutics (NASDAQ:BLPH)
Insider Ownership Percentage: 54.20%
Institutional Ownership Percentage: 44.39%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/17/2016Jonathan M PeacockCEOBuy5,000$1.37$6,850.00View SEC Filing  
12/16/2015Jonathan M. PeacockCEOBuy20,300$2.75$55,825.00View SEC Filing  
8/19/2015Jonathan M PeacockCEOBuy5,000$5.48$27,400.00View SEC Filing  
5/20/2015Jonathan M PeacockCEOBuy5,560$8.69$48,316.40View SEC Filing  
2/19/2015Daniel TasseDirectorBuy25,000$12.00$300,000.00View SEC Filing  
2/19/2015Jonathan M PeacockCEOBuy20,800$12.00$249,600.00View SEC Filing  
2/19/2015Linde North America, Inc.Major ShareholderBuy358,916$12.00$4,306,992.00View SEC Filing  
2/19/2015Manesh NaiduInsiderBuy1,500$12.00$18,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bellerophon Therapeutics (NASDAQ:BLPH)
DateHeadline
News IconKeen Investors Find News on Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Duncan Research (NASDAQ:BLPH)
www.duncanindependent.com - September 24 at 8:07 AM
News IconStock Tracker: Earnings & Estimates for Bellerophon Therapeutics Inc (NASDAQ:BLPH) - Frisco Fastball (NASDAQ:BLPH)
friscofastball.com - September 23 at 8:58 AM
News IconUnder the Microscope, Zeroing in at Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Duncan Research (NASDAQ:BLPH)
www.duncanindependent.com - September 22 at 4:02 PM
News IconBellerophon Therapeutics Inc (NASDAQ:BLPH) Given $8.50 Consensus Target Price by Analysts - DailyQuint (NASDAQ:BLPH)
dailyquint.com - September 21 at 3:19 PM
globenewswire.com logoBellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 - GlobeNewswire (press release) (NASDAQ:BLPH)
globenewswire.com - September 21 at 3:19 PM
News IconPenny Stock Investors Take an Interest in Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Duncan Research (NASDAQ:BLPH)
www.duncanindependent.com - September 21 at 8:25 AM
streetinsider.com logoBellerophon Therapeutics (BLPH) CEO Peacock to Retire; Successor Named - StreetInsider.com (NASDAQ:BLPH)
www.streetinsider.com - September 20 at 9:45 AM
biz.yahoo.com logoBELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:BLPH)
biz.yahoo.com - September 20 at 9:45 AM
publicnow.com logoBellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 (NASDAQ:BLPH)
www.publicnow.com - September 20 at 9:45 AM
News IconLooking Ahead for Bellerophon Therapeutics Inc (NASDAQ:BLPH); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:BLPH)
friscofastball.com - September 17 at 3:48 PM
News IconAnalysts Take the Wheel on Bellerophon Therapeutics Inc (NASDAQ:BLPH) Shares and Where They Might Be Headed - Frisco Fastball (NASDAQ:BLPH)
friscofastball.com - September 15 at 3:40 PM
News IconAnalysts Place Bellerophon Therapeutics Inc (NASDAQ:BLPH) Under the Lens of the Microscope - Post News (NASDAQ:BLPH)
www.kentuckypostnews.com - September 12 at 8:39 AM
News IconShares Trading Lower in Today's Session: Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Post News (NASDAQ:BLPH)
www.kentuckypostnews.com - September 6 at 3:36 PM
finance.yahoo.com logoBellerophon to Present at the 18th Annual Rodman & Renshaw Global Investment Conference (NASDAQ:BLPH)
finance.yahoo.com - September 6 at 8:41 AM
finance.yahoo.com logoBELLEROPHON THERAPEUTICS, INC. Financials (NASDAQ:BLPH)
finance.yahoo.com - August 17 at 3:58 PM
cnbc.com logoBellerophon Therapeutics posts 2Q loss (NASDAQ:BLPH)
www.cnbc.com - August 9 at 12:49 PM
publicnow.com logoBellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:BLPH)
www.publicnow.com - August 9 at 12:49 PM
biz.yahoo.com logoBELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement (NASDAQ:BLPH)
biz.yahoo.com - August 9 at 12:49 PM
kcregister.com logoTrending Stocks: Mercury General Corporation (NYSE:MCY), Bellerophon Therapeutics, (NASDAQ:BLPH), 3D Systems ... - KC Register (NASDAQ:BLPH)
www.kcregister.com - July 28 at 12:39 PM
biz.yahoo.com logoBELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:BLPH)
biz.yahoo.com - July 27 at 7:54 AM
4-traders.com logoBellerophon Therapeutics : Receives Approval to Commence Phase 2 Trial in PH-COPD (NASDAQ:BLPH)
www.4-traders.com - July 26 at 9:52 PM
News IconBellerophon Therapeutics, Inc. (NASDAQ:BLPH) Hopes To Conclude INOpulse Clinical Trial For PH-COPD By Year-End After Getting Approval For Phase Study (NASDAQ:BLPH)
wallstreetpr.com - July 26 at 9:52 PM
News IconTerraForm Power Inc (NASDAQ:TERP) & Bellerophon Therapeutics (NASDAQ:BLPH) Active Stock's Momentum - Money News (press release) (NASDAQ:BLPH)
www.newsismoney.com - July 26 at 3:46 PM
News IconAnalysts Chime In On Tobira Therapeutics Inc (NASDAQ:TBRA), Bellerophon Therapeutics Inc (NASDAQ:BLPH) - Post Registrar (NASDAQ:BLPH)
postregistrar.com - July 26 at 3:46 PM
News IconJust In: Sprint Corp (NYSE:S), Bellerophon Therapeutics Inc (NASDAQ:BLPH) - Market News Call (NASDAQ:BLPH)
www.marketnewscall.com - July 26 at 10:49 AM
streetinsider.com logoBellerophon Therapeutics (BLPH) Approved to Commence PH-COPD Phase 2 (NASDAQ:BLPH)
www.streetinsider.com - July 25 at 4:25 PM
finance.yahoo.com logoBellerophon Gets Approval To Start Second Stage Study In PH-COPD (NASDAQ:BLPH)
finance.yahoo.com - July 25 at 12:05 PM
benzinga.com logo13 Stocks Moving In Monday's Pre-Market Session - Benzinga (NASDAQ:BLPH)
www.benzinga.com - July 25 at 8:39 AM
streetinsider.com logoBellerophon Therapeutics (BLPH) Approved to Commence PH-COPD Phase 2 - StreetInsider.com (NASDAQ:BLPH)
www.streetinsider.com - July 25 at 8:39 AM
publicnow.com logoBellerophon Receives Approval to Commence Phase 2 Trial in PH-COPD (NASDAQ:BLPH)
www.publicnow.com - July 25 at 6:18 AM
finance.yahoo.com logo6:04 am Bellerophon Therapeutics announces approval to commence Phase 2 trial for INOpulse to treat pulmonary hypertension in chronic obstructive pulmonary disease (PH-COPD) (NASDAQ:BLPH)
finance.yahoo.com - July 25 at 6:04 AM
News IconStock Alert: Unusual Volume Watch for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 23 at 8:07 AM
News IconEquity Roundup: Stock Performance Focus on Bellerophon Therapeutics Inc (NASDAQ:BLPH) - Press Telegraph (NASDAQ:BLPH)
presstelegraph.com - July 23 at 8:07 AM
News IconBellerophon Therapeutics Inc Stock Price Increases Today - Consumer Eagle (NASDAQ:BLPH)
www.consumereagle.com - July 21 at 12:23 PM
News IconBellerophon Therapeutics Inc (NASDAQ:BLPH): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 21 at 12:23 PM
News IconChecking in on Stock Volatility for: Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 21 at 12:23 PM
News IconIncreased Stock Volatility Watch: Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 21 at 12:23 PM
News IconBellerophon Therapeutics Inc (NASDAQ:BLPH) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:BLPH)
telanaganapress.com - July 18 at 3:58 PM
fiscalstandard.com logoBellerophon Therapeutics, Inc. (BLPH) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BLPH)
www.fiscalstandard.com - July 17 at 8:33 AM
News IconIncreased Volatility Noted on Shares of: Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 16 at 8:40 AM
ftsenews.co.uk logoBellerophon Therapeutics, Inc. (BLPH) Updated Price Targets - FTSE News (NASDAQ:BLPH)
www.ftsenews.co.uk - July 16 at 8:40 AM
seekingalpha.com logoBellerophon Therapeutics Is More Than A One-Trick Pony - Seeking Alpha (NASDAQ:BLPH)
seekingalpha.com - July 14 at 9:22 PM
News IconBellerophon Therapeutics Incorporated (NASDAQ:BLPH) Shorted Shares Increased By 184.52% - Consumer Eagle (NASDAQ:BLPH)
www.consumereagle.com - July 13 at 9:19 PM
News IconBellerophon Therapeutics Inc (NASDAQ:BLPH) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 13 at 9:19 PM
News IconWall Street Ratings and Target Price Views on Bellerophon Therapeutics Inc (NASDAQ:BLPH) - Telanagana Press (NASDAQ:BLPH)
telanaganapress.com - July 13 at 3:53 PM
News IconCan Bellerophon Therapeutics Inc (NASDAQ:BLPH) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 7 at 3:51 PM
News IconBellerophon Therapeutics Incorporated (NASDAQ:BLPH) Short Interest Increased By 184.52% - Engelwood Daily (NASDAQ:BLPH)
www.engelwooddaily.com - July 1 at 11:55 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Bellerophon Therapeutics, Inc. (BLPH) - Fiscal Standard (NASDAQ:BLPH)
www.fiscalstandard.com - July 1 at 11:55 AM
fiscalstandard.com logoBroker Outlook For The Week Ahead Bellerophon Therapeutics, Inc. (BLPH) - Fiscal Standard (NASDAQ:BLPH)
www.fiscalstandard.com - June 28 at 8:20 AM
News IconCovering the Bases on Bellerophon Therapeutics Inc (NASDAQ:BLPH): Where is the Stock Going? - Press Telegraph (NASDAQ:BLPH)
presstelegraph.com - June 28 at 8:20 AM

Social

Bellerophon Therapeutics (NASDAQ:BLPH) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff